Skip to main content

Lineage Cell Therapeutics, Inc 10-Q for FY2024 Q1

Lineage Cell Therapeutics, Inc. (LCTX)

10-Q 2024-05-09 For: 2024-03-31
View Original
Added on April 12, 2026

About this 10-Q

Lineage Cell Therapeutics, Inc filed this 10-Q on May 9, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.44M
down 39.5% from $2.39M a year earlier
Net loss
$6.54M
compared with a net loss of $4.37M a year earlier
Diluted EPS
-$0.04
compared with -$0.03 a year earlier